Sara Aledaili

The proportion of infections in patients with vascular anomalies treated with sirolimus: a retrospective study

Sirolimus, an mTOR inhibitor, is an effective treatment for vascular anomalies (VA), particularly lymphatic malformations. However, its immunosuppressive properties raise concerns regarding infection risk, while the role of antibiotic prophylaxis remains unclear. This study aims...